Search by Drug Name or NDC

NDC 69097-0820-96 Zemdri (plazomicin) 500 mg/10mL Details

Zemdri (plazomicin) 500 mg/10mL

Zemdri (plazomicin) is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cipla USA Inc.. The primary component is PLAZOMICIN.

MedlinePlus Drug Summary

Plazomicin injection is used to treat serious urinary tract infections, including kidney infections, that are caused by bacteria. Plazomicin injection is in a class of medications called aminoglycoside antibiotics. It works by killing bacteria. Antibiotics such as plazomicin injection will not work for colds, flu, or other viral infections. Taking or using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.

Related Packages: 69097-0820-96
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Plazomicin Injection

Product Information

NDC	69097-0820
Product ID	69097-820_3c4cf8ae-081c-476a-8c47-581407c20fe2
Associated GPIs	07000054102030
GCN Sequence Number	078569
GCN Sequence Number Description	plazomicin sulfate VIAL 500MG/10ML INTRAVEN
HIC3	W1F
HIC3 Description	AMINOGLYCOSIDE ANTIBIOTICS
GCN	44919
HICL Sequence Number	045034
HICL Sequence Number Description	PLAZOMICIN SULFATE
Brand/Generic	Brand
Proprietary Name	Zemdri (plazomicin)
Proprietary Name Suffix	n/a
Non-Proprietary Name	Plazomicin
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	INJECTION
Route	INTRAVENOUS
Active Ingredient Strength	500
Active Ingredient Units	mg/10mL
Substance Name	PLAZOMICIN
Labeler Name	Cipla USA Inc.
Pharmaceutical Class	n/a
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA210303
Listing Certified Through	2024-12-31

Package

NDC 69097-0820-96 (69097082096)

Pricing Information	N/A
NDC Package Code	69097-820-96
Billing NDC	69097082096
Package	10 VIAL in 1 CARTON (69097-820-96) / 10 mL in 1 VIAL (69097-820-37)
Marketing Start Date	2018-07-16
NDC Exclude Flag	N